Market Opportunity

A multi-billion-pound market with a position no one occupies

£0.0BGlobal market (2024)

Growing at 5–7% per year through 2030

The global mosquito control market is driven by public health mandates, NGO procurement, and rising consumer demand for non-toxic alternatives. Sub-Saharan Africa, South Asia, and Southeast Asia represent the highest-volume opportunity — with the UK and Europe as accessible near-term launch markets.

No existing product addresses individual-level adaptive acoustic repulsion. ISARS enters a proven, large market with a demonstrably superior approach to a problem that current solutions have failed to fully solve.

Target Segments

Six routes to revenue

Households — Endemic Regions

Phase 1

NGO supply & direct distribution

UK & European Consumer

Phase 1

E-commerce & retail partnerships

Healthcare Facilities

Phase 2

B2B bulk supply to clinics & hospitals

Travel & Tourism

Phase 2

Premium retail tier for travellers

Public Health Programmes

Phase 3

Government & donor procurement

Technology Licensing

Phase 3

OEM & platform integration

Commercial Model

Multiple paths to revenue

Device Sales

Consumer and retail sales at a target price of £70 per device through e-commerce and distribution partners worldwide.

Institutional Supply

Bulk supply agreements with healthcare organisations, NGOs, and government health ministries at volume pricing.

Software & Data Services

Subscription tier for over-the-air model updates as the dataset expands. Aggregated population-level data has value to epidemiologists.

Technology Licensing

Licensing of the acoustic identification and adaptive response methodology to OEM manufacturers and IoT platform providers.

Regulatory Pathway

Built toward the standards our customers require

ISARS is being engineered against the regulatory benchmarks that govern procurement in our target markets. None of the following represents current certification — this is the pathway we are actively working towards.

WHO Vector Control Prequalification

The key international benchmark for public health vector-control devices — assessment pathway identified.

UK / EU Market Access

UKCA and CE marking — assessment in progress.

Target Markets

Five beachhead countries

Selected by total population and the share of that population affected by malaria each year — the two factors that determine the size of the addressable, highest-need household market in each country.